Pipenzolate bromide

  1. Home
  2. Wiki

Pipenzolate bromide
Clinical data
ATC code
Identifiers
  • 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.004.311 Edit this at Wikidata
Chemical and physical data
FormulaC22H28BrNO3
Molar mass434.374 g·mol−1
3D model (JSmol)
  • CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-]
  • InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 ☒N
  • Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M ☒N
 ☒NcheckY (what is this?)  (verify)

Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1][2]

Mechanism of action

[edit]

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]

References

[edit]
  1. ^ a b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.
  2. ^ Ivey KJ (January 1975). "Anticholinergics: do they work in peptic ulcer?". Gastroenterology. 68 (1): 154–166. doi:10.1016/S0016-5085(75)80062-X. PMID 1090477.
Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.